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neuropathological evaluation in pituitary 
adenomas treated via transphenoidal 
route
AbsTArcT
Introduction: There are some discrepancies between immunohistochemical staining results and clinical 
picture of pituitary adenomas. Such a discordance may be caused by multiple factors. The problem of 
securing the histopathological material during the transsphenoidal pituitary surgery and its reliability for 
neuropathological evaluation deserves a special attention. The surgical biopsy does not always meet the 
criteria required for a immunohistochemical staining and sometimes not even for the routine histopatho-
logical examination.
Aims: To determine the frequency of unreliable material for histopathological examination and factors 
influencing the reliability of histopathological specimens after surgery for pituitary adenomas.
Material and methods. The hematoxylin and eosin sections were examined in detail. with a special attention 
to the presence of incidental findings, i.e. admixture of normal pituitary gland tissue, signs of hemorrhage, 
necrosis, thermal artifacts, inflammatory changes, respiratory epithelium, vessels or cholesterol granuloma. 
The impact of incidental findings on further immunohistochemical analysis was investigated. The relationship 
between the magnetic resonance imaging (MRI)- determined tumor size and the area of histopathological 
specimen was assessed and considered as a reliability parameter.
Results: The unreliable material was estimated at the level of 11.8%. It was assessed that hemorrhages, 
neurohypophysis, necrosis and quantity of collected histopathological material had the statistically sig-
nificant impact on the reliability of the histopathological material. The statistical analysis did not show any 
relation between the reliability of the histopathological material and the MRI-determined volume of the tumor. 
Conclusions: The presence of some additional tissue elements and artifacts in the histopathological 
specimen makes the immunohistochemical evaluation difficult or even impossible. However, this problem 
is related to a relatively low percentage of cases, mainly small tumors.
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Introduction
The routine diagnostics of the pituitary tumors 
is complex. It is based on clinical, endocrinological, 
radiological and neuropathological evaluation [1–3].
The histopathological diagnosis of removed adeno-
ma is crucial for further treatment and prognosis [4–6]. 
By analyzing histopathological features we are able to 
predict the possible clinical course of pituitary adenomas 
[7–8]. Neuropathological examination of the specimen 
obtained from the material collected during the surgery 
relays, except routine hematoxylin and eosin (H&E) 
staining, on series of the immunohistochemical exam-
inations as well as on ultrastructural evaluation [9–13].
For the pituitary tumors diagnostics, a very important 
issue is the reliability of the histopathological speci-
men. The specimen is considered reliable if allows to 
determine the histopathological diagnosis, regardless 
of the specimen size. It means that from the formalin 
embedded tumor we have to obtain at least eight 
specimens (H&E, immunohistochemical stainings for 
anterior lobe hormones and alpha-subunit). However, 
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Figure 2A. Pseudolobular structure of the adenoma imitating normal adenopituitary structure; B. Pituitary adenoma. Staining 
for ACTH. Normal adenohypophisis positive for ACTH is seen; C. Pilocytic astrocytoma; D. Normal adenohypophysis.
Figure 1. Specimen obtained during transspehenoidal 
surgery for pituitary adenoma
the histopathological material is not always collected in 
sufficient amount during the surgery. It may result from 
the size of the tumor itself. Theoretically, the greater 
tumor we treat the greater material should be obtained 
for the histopathological investigation. However, it is 
not always the rule, because it may be influenced by 
different factors. Contemporary art of pituitary tumor 
surgery leads to minimization of the surgical approach 
and obtaining small amount of material for histopatho-
logical examination. The pituitary adenomas are usually 
easily removed during the surgery due to their soft, often 
semi-fluid consistency (Fig. 1). On the other side, it may 
determine difficulties while collecting the tumor mass 
for histopathological investigation, because it can be 
inadvertently aspirated. Because of the small volume, 
a sample run dry quickly, therefore an immediate trans-
fer to the neuropathological lab is crucial. 
An appropriate interpretation of the histopathologi-
cal examination might be impaired by the presence of 
the regular components of the pituitary gland (adenohy-
pophysis, neurohypophysis), other tissue elements and 
additional pathological findings (Fig. 2B). Commonly 
encountered are bleeding traces (siderophags, hemo-
siderin and hematin deposits), less often cholesterol 
granuloma, amyloid deposits (in case of some prolac-
tinoma and somatotropinoma), calcifications (mainly 
prolactinoma). [9,14–15] Differentiating between ade-
nohypophysis and the adenoma might be difficult even 
for an experienced neuropathologist, particularly when 
adenoma is accompanied by hyperplastic cells (mainly 
corticotrophs and mammotrophs) [16]. In a number of 
cases, tissue of neurohypophysis is taken together with 
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the tissue of adenoma. It may be mistaken with pilocytic 
astrocytoma because of it morphological similarity. 
(Fig. 2C and 2D) 
From the neurosurgical perspective, it is important 
to confirm the diagnosis of pituitary adenoma. In turn 
for a neuropathologist adequate amount of material pro-
vides possibility of bright spectrum of histopathological 
analysis including the panel of immunohistochemical 
staining. 
We aimed to determine the frequency of unreliable 
material for histopathological examination and factors 
influencing the reliability of histopathological specimens 
after surgery for pituitary adenomas. The lack of suffi-
cient knowledge in that field and discrepancies in the 
literature explain the purpose of the study.
Material and methods
We enrolled patients operated in the Department 
of Neurosurgery and subsequently diagnosed in the 
Department of Neuropathology during ten year-pe-
riod (2007–2016). The final study group consisted 
of 72 (44 females) patients aged between 10 and 
84 years (mean age: 46.9 years) with complete clin-
ical, histopathological and radiological records. All 
patients were operated microsurgically through the 
sphenoid sinus. Specimens were embedded in paraf-
fin. Then, in all cases routine H&E staining was carried 
out alongside with full panel of immunohistochemical 
staining for hormones of the adenohypophysis, such 
as: prolactine (anti-PRL, Dako, Denmark), growth hor-
mone (anti-GH, Dako, Denmark), adronocorticothropic 
hormone (anti-ACTH, Dako, Denmark), thyreotropic 
hormone (anti-TSH, Novocastra, Great Brittan), lute-
thropic and follicular hormones (anti-LH and anti-FSH, 
Dako, Denmark and a-subunite (anti-a-SU, Novocastra, 
Great Brittan). All sections were examined using light 
microscope Nikon Optishot-2 under magnification of 
200x and 400x. 
Radiological analysis of the tumor was based on 
magnetic resonance imaging of the sellar region. The 
tumor volume was calculated using the Di Chiro and 
Nelson formula V=(π/6)×(x×y×z) and was given in 
cubic millimeters (mm3) [17].
Area of specimen was calculated using ImageJ 
software v. 1.43 k (National Institute of Health, USA). 
In cases of specimen fragmentation the areas of frag-
ments were calculated separately and added. Area of 
specimen is given in square millimeters (mm2).
Statistical analysis
The results were presented using descriptive statis-
tical methods, including ranges, means, standard devi-
ations, and percentage distributions. Continuous vari-
ables were assessed using the t-test or Mann-Whitney 
U test when appropriate. Proportions were assessed 
using the Pearson’s c2 test. The Pearson’s correlation 
coefficient was used to establish the relation between 
volume of the adenoma and area of a histopathologi-
cal specimen.
Statistical analyses were performed using Statistica 
9.0 PL, (StatSoft, Poland).
results
Five hundred and four immunohistochemically 
stained specimens derived from 72 patients were 
analyzed. Eighty four specimens were positive for 
adenoma tissue. We observed one or more positive 
immunohistochemical reactions in 43 patients. We di-
agnosed 22 monohormonal (30.56%) 21 plurihormonal 
(29.17%) and 21 (29.17%) adenomas with negative 
hormonal staining. In 8 cases (11.11%), we were 
not able to interpret immunohistochemical staining. 
Therefore, in these cases, we recognized specimen 
as unreliable. Macroadenomas and microadenomas 
were diagnosed in 51 (70.84%) and 21 (29.16%) cases, 
respectively.
Mean tumor volume was 6405.01 ± 12068.27 mm3. Mean 
area of specimen was 41.79 ± 37.79 mm². Association 
between area of specimen and tumor volume was posi-
tive when tested with the Pearson’s correlation coefficient 
(r = 0.496, p < 0.001) — Fig. 3. There was no correlation 
between unreliable specimen and tumor volume. Unreli-
able specimens had significantly smaller area (Table I). 
The most frequent incidental finding in specimen 
was adenohypophisis fragments, found in 29 cases 
(40.28%). In unreliable specimen, there was a higher in-
cidence of hemorrhage (75.00% vs. 21.88%; p = 0.002), 
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Figure 3. The relationship between the histopathological 
specimen area and the tumor volume
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Table 1. The tumor volume based on MRI and H&E specimen area in the groups of reliable and unreliable specimens
Unreliable Reliable
p value
n Av. SD Min. Max. n Av. SD Min. Max.
Volume (mm3) 8 729.41 978.12 18.8 2825 64 7114.46 12626.54 6.2 70475 p=0.159
Area (mm2) 8 14.41 14.01 0.55 36.71 64 45.22 38.48 1.22 156.15 p=0.028
Table 2. The reliability of the specimens and additional findings
Incidental findings Unreliable (n=8) Reliable (n=64)
n % n % p value
Adenohypophysis 3 37.50 26 40.62 NS
Hemorrhage 6 75.00 14 21.88 p=0,002
Neurohypophysis 3 37.50 2 3.13 p=0,004
Necrosis 2 25.00 1 1.56 p=0,002
Thermal artefacts 1 12.50 2 3.13 NS
Inflammatory changes 0 0 2 3.13 NS
Fibrosis 0 0 2 3.13 NS
Hyalinisation 0 0 2 3.13 NS
Neural tissue of the hypothalamus 0 0 1 1.56 NS
Respiratory epithelium 0 0 1 1.56 NS
Vessels 0 0 1 1.56 NS
Cholesterol granuloma 0 0 1 1.56 NS
Dried material 1 12.50 0 0 NS
neurohypophysis tissue (37.50% vs. 3.13%; p = 0.004) 
and necrosis (25.00% vs. 1.56%; p = 0.002) (Table II).
Discussion
In our study, we established the incidence of unreli-
able histopathological specimen of pituitary adenomas 
at the level of 11.11%. Moreover, we found a significant 
correlation between the area of specimen and its reli-
ability, but there is no correlation between the tumor 
volume and the reliability of the specimen. The factors 
most frequently associated with specimens unreliability 
included: hemorrhage, incidental neurohypophysis 
tissue and necrosis. Those additional findings play 
a role especially in case of small area specimens, where 
available field for histopathological examination was 
critically reduced.
Histopathological diagnosis of pituitary adenomas is 
based on routine histopathological staining as well as 
immunoexpression of the pituitary hormones [18]. The 
World Health Organization (WHO) standards despite 
thorough description of the diagnostic criteria for pitu-
itary adenoma are mute in case of unreliable material 
[19–20]. Therefore it is a surgeon’s duty to preserve the 
reliable specimen to allow the accurate diagnosis while 
removing adenoma. This is dependent on a number of 
circumstances such as the size and consistence of the 
tumor, bleeding during surgery and handling with the 
specimen after its removal. 
The relation between the available histopathological 
material and tumor size was investigated. The relation 
of the adenoma volume (according to the MRI picture) 
and specimen area was recognized as a reliability 
parameter. The strong correlation between those two 
parameters was found (p < 0.001). The statistical 
analysis showed clearly that the greater the volume 
of the tumor, the greater amount of collected histo-
pathological material. On the other hand, analyzing the 
diagram that shows the relation between adenomas 
volume and area of the specimens, the curve trend 
exist through few points corresponding to the large 
tumors. However most of the points were focused in 
the portion of the diagram corresponding to small and 
medium tumors. Tumors that did not differ much in size 
are represented by specimens of huge spread of area 
(Fig. 3). It seemed that it bared witness to a great impact 
of the neurosurgeon and intraoperative conditions on 
the amount of collected histopathological material. It is 
necessary to excuse the surgeon in case of very small 
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tumors, where securing of the histopathological material 
may be difficult. Notwithstanding it is not possible to 
define the smallest size of the adenoma with reliable 
histopathological material, because even based on 
very small tumors it is possible to prepare conclusive 
specimens. 
The previous WHO classification mentioned that 
only a small number of pituitary tumors remained un-
diagnosed and categorized as unclassified adenomas 
[21]. This fact is mentioned by Saeger et al. [6]. That cat-
egorization is not followed in the 2017 classification [19]. 
This study found that pituitary adenomas recognized 
as unclassified are more frequently diagnosed based 
on small specimen with higher incidence of necrosis 
and atypical structures. Other authors mentioned only 
unreliable specimens and usually exclude them from 
the study group [16]. Knosp et al. also acknowledge 
the fact that small specimen may not be representative 
enough for accurate immunohistochemical staining and 
accurate diagnosis [22]. 
Overall unreliability of histopathological specimen 
in our study was established a little over 11%. This 
frequency is similar to one described by Saeger et al, 
which was 8% [23]. In study by Maksymowicz et al., 
unreliability was established at 16.3% and was mainly 
associated with small specimens size and presence of 
normal pituitary tissue admixture [16]. 
The awareness of an operating neurosurgeon of the 
importance of meticulous collecting histopathological 
material, especially in microadenoma cases, has essen-
tial impact on further neuropathological evaluation and 
possibility of immunohistochemical staining.
In conclusion, the presence of some additional 
tissue elements and artifacts in the histopathological 
specimen makes the immunohistochemical evaluation 
difficult or even impossible. However, this problem 
relates to a relatively small percentage of cases, 
mainly small tumors. In those cases, the resignation of 
intraoperative histopathological investigation should 
be considered.
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